Inflammatory markers in clinical practice. - Wikidata - wikimedia - TriplyDB

Inflammatory markers in clinical practice.

Inflammatory markers in clinical practice.

http://www.wikidata.org/entity/Q33996625

about

Modulation of Immune Functions by Foods Pediatrics, surfactant, and cystic fibrosis in AJRCCM 2000.Relationship between exhaled carbon monoxide and airway hyperresponsiveness in asthmatic patients.

P2860

Q24808820-30CDBF5A-5B12-46AC-A16B-C6DD3199A00D Q34446631-F9F3CC95-8234-45A8-B50E-2B0CF043E2C7 Q44815729-A2D116A0-325E-49FF-A0A3-A553EC898063

P2860

Inflammatory markers in clinical practice.

http://www.wikidata.org/entity/Q33996625

description

2000 nî lūn-bûn

@nan

2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Inflammatory markers in clinical practice.

@ast

Inflammatory markers in clinical practice.

@en

type

label

Inflammatory markers in clinical practice.

@ast

Inflammatory markers in clinical practice.

@en

prefLabel

Inflammatory markers in clinical practice.

@ast

Inflammatory markers in clinical practice.

@en

P1433

Q33996625-D5152973-4B01-4772-BC2F-84C3784112D6

P1476

Q33996625-1197F853-0201-4184-8B21-9A8921777949

P2093

Q33996625-AEE5E933-C4B5-4AA0-A529-5471E3BB642C

Q33996625-E194FB6A-7772-451D-AF97-779392ABE3FF

P2860

Q33996625-291D2E9D-BEDD-49F2-8648-A5826E9FB396

Q33996625-2D440E46-E9D6-491F-A5FD-C5B70F2C0650

Q33996625-3843C1A0-1508-461C-B3B5-161EED959CC1

Q33996625-390D70D6-4D17-456D-8082-E08B483D5B94

Q33996625-996525B1-E450-4313-8369-261FA70DDBC3

Q33996625-B637B68C-DF72-4B1E-9EA9-E05ECB97C293

Q33996625-BCDB0469-74BA-4DBF-A206-40587CE285B2

Q33996625-C728CD61-BE5C-4817-B426-B0A131AAE565

P304

Q33996625-976FA8A3-5C58-4ADF-8A0B-A82434BEB3E9

P31

Q33996625-DF4AEDBC-FF9C-4915-98AE-D69E395368A7

P356

Q33996625-81191B24-2472-4927-8A9C-2CAECBAF191C

P407

Q33996625-46408D04-E47B-4406-B20E-D190F2D03E87

P433

Q33996625-B4614C64-2A86-4715-81D4-5481AEC1437E

P478

Q33996625-BED26FB8-75EB-48A9-9A66-13C0BDA6AC28

P577

Q33996625-EA6D07FF-7895-4371-9ED0-CE0FF71B3758

P698

Q33996625-FF3CDE9F-01A2-42F4-B51E-0CD4B089A889

P356

AJRCCM.162.SUPPLEMENT_1.MAIC-13

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Inflammatory markers in clinical practice.

@en

P2093

Pedersen S

http://www.w3.org/2001/XMLSchema#string

Wilson N

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma

Eosinophilic activation in cystic fibrosis.

Incidence and prognosis of asthma and wheezing illness from early childhood to age 33 in a national British cohort.

Sensitization to inhalant allergens in wheezing infants is predictive of the development of infantile asthma.

Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group.

Eosinophil cationic protein in nasopharyngeal secretions and serum of infants infected with respiratory syncytial virus.

Eosinophil cationic protein in nasal secretion and in serum and myeloperoxidase in serum in respiratory syncytial virus bronchiolitis: relation to asthma and atopy.

The relationship of serum-eosinophil cationic protein and eosinophil count to disease activity in children with bronchial asthma.

P304

S48-51

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/AJRCCM.162.SUPPLEMENT_1.MAIC-13

http://www.w3.org/2001/XMLSchema#string

P407

P433

2 Pt 2

http://www.w3.org/2001/XMLSchema#string

P478

162

http://www.w3.org/2001/XMLSchema#string

P577

2000-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10934134

http://www.w3.org/2001/XMLSchema#string